For when it \ 'everything, sometimes at the beginning or middle of next year, a new leadership, have begun to appear in our financial industry, which no longer paying lip service on world markets, but is born effect on them.
Merck & Co. Recalled 1.2 million doses of a vaccine for childhood because of the potential contamination during the manufacturing process. However, the vaccine does not pose a health threat, health officials in the United States said Wednesday.
The company has voluntarily recalled two batches of the Haemophilus influenzae type B (Hib) vaccine. Haemophilus influenzae is a group of bacteria that can cause different types of infections in infants and children. They include ear, eye or sinus infections and pneumonia. The most serious, but rare strain can cause meningitis and a life-threatening infection called epiglottitis.
Vaccination is recommended for all children under 5 and is usually given in a series of three, from 2 months.
\ "The CDC and the FDA has learned this week that Merck, one of two companies that offer the Hib vaccine, recalling some batches of vaccine, \" Dr. Julie Gerberding, director of the US Centers for Disease Control and Prevention, said at a Late afternoon teleconference. \ "For the moment, it is not a health hazard for children."
There has been no reported cases of adverse effects with the Hib vaccine, Gerberding said. \ "The recall has nothing to do with the potency of the vaccine, so that the children who received the vaccine were protected, \" she said.
Gerberding noted that the Haemophilus influenzae type B is a bacterium and has nothing to do with the influenza virus.
Before vaccination, there were about 20000 cases of Hib disease in the United States each year, resulting in about 1000 deaths, according to the CDC.
\ "But through immunization, there are fewer than 100 documented cases of Hib disease in the United States each year -- a reduction of more than 99 per cent \ "Gerberding said.
The vaccine is made by both Merck and Sanofi Pasteur. The recall involves lots of Merck \ 'PedvaxHIB and Comvax shipped after April 2007.
It \ 'is not known how many of the 1.2 million doses have been given to children. But even children who received a vaccine to any of the recalled batches are not at risk of any health problems, Gerberding said.
Gerberding expects that the recall will result in shortages of vaccine, but it does not expect any increase in the disease, as many children were vaccinated.
\ "We are sorry for the parents who will be inconvenienced, \" she said.
Merck identified the problem during routine tests of the manufacturing process at a plant in Pennsylvania, Dr. Norman Baylor, director of the U.S. Food and Drug Administration \ 'Office of Vaccine Research and Review, said during the teleconference.
\ "Merck identified an issue that creates a risk for microorganisms to survive sterilization step in the manufacture, \" Baylor said. \ "Not documented contamination of the vaccine was found."
Parents whose children have recently been vaccinated against Hib can look bumps skin or abscesses at the site of ; injection, which could indicate a potential problem, "said Dr. Anne Schuchat, the CDC \ 'director of the National Center for Immunization and Respiratory Diseases. But she did not specify what those problems might be.
\ "This sort of thing might emerge over one week after vaccination, \" Schuchat said. \ "We don \ 't have any of these reports."
The CDC is reviewing the Hib vaccine supply throughout the country to see what can be made to alleviate any shortage occurs, she said.
More
Article Generated by: Blogger Post Content | Short Video Site
Merck & Co. Recalled 1.2 million doses of a vaccine for childhood because of the potential contamination during the manufacturing process. However, the vaccine does not pose a health threat, health officials in the United States said Wednesday.
The company has voluntarily recalled two batches of the Haemophilus influenzae type B (Hib) vaccine. Haemophilus influenzae is a group of bacteria that can cause different types of infections in infants and children. They include ear, eye or sinus infections and pneumonia. The most serious, but rare strain can cause meningitis and a life-threatening infection called epiglottitis.
Vaccination is recommended for all children under 5 and is usually given in a series of three, from 2 months.
\ "The CDC and the FDA has learned this week that Merck, one of two companies that offer the Hib vaccine, recalling some batches of vaccine, \" Dr. Julie Gerberding, director of the US Centers for Disease Control and Prevention, said at a Late afternoon teleconference. \ "For the moment, it is not a health hazard for children."
There has been no reported cases of adverse effects with the Hib vaccine, Gerberding said. \ "The recall has nothing to do with the potency of the vaccine, so that the children who received the vaccine were protected, \" she said.
Gerberding noted that the Haemophilus influenzae type B is a bacterium and has nothing to do with the influenza virus.
Before vaccination, there were about 20000 cases of Hib disease in the United States each year, resulting in about 1000 deaths, according to the CDC.
\ "But through immunization, there are fewer than 100 documented cases of Hib disease in the United States each year -- a reduction of more than 99 per cent \ "Gerberding said.
The vaccine is made by both Merck and Sanofi Pasteur. The recall involves lots of Merck \ 'PedvaxHIB and Comvax shipped after April 2007.
It \ 'is not known how many of the 1.2 million doses have been given to children. But even children who received a vaccine to any of the recalled batches are not at risk of any health problems, Gerberding said.
Gerberding expects that the recall will result in shortages of vaccine, but it does not expect any increase in the disease, as many children were vaccinated.
\ "We are sorry for the parents who will be inconvenienced, \" she said.
Merck identified the problem during routine tests of the manufacturing process at a plant in Pennsylvania, Dr. Norman Baylor, director of the U.S. Food and Drug Administration \ 'Office of Vaccine Research and Review, said during the teleconference.
\ "Merck identified an issue that creates a risk for microorganisms to survive sterilization step in the manufacture, \" Baylor said. \ "Not documented contamination of the vaccine was found."
Parents whose children have recently been vaccinated against Hib can look bumps skin or abscesses at the site of ; injection, which could indicate a potential problem, "said Dr. Anne Schuchat, the CDC \ 'director of the National Center for Immunization and Respiratory Diseases. But she did not specify what those problems might be.
\ "This sort of thing might emerge over one week after vaccination, \" Schuchat said. \ "We don \ 't have any of these reports."
The CDC is reviewing the Hib vaccine supply throughout the country to see what can be made to alleviate any shortage occurs, she said.
More
Article Generated by: Blogger Post Content | Short Video Site
No comments:
Post a Comment